XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 18.18%6.16B | 0.35%10.76B | 7.85%5.21B | 38.57%10.72B | 50.96%4.83B | 70.93%7.74B | 68.57%3.2B | 26.66%4.53B | 18.11%1.9B | 12.48%3.57B |
Operating income | 18.18%6.16B | 0.35%10.76B | 7.85%5.21B | 38.57%10.72B | 50.96%4.83B | 70.93%7.74B | 68.57%3.2B | 26.66%4.53B | 18.11%1.9B | 12.48%3.57B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Employee expense | -33.56%-538.38M | -38.06%-938.82M | -13.57%-403.1M | -14.52%-680.02M | -32.57%-354.93M | -40.27%-593.82M | -40.96%-267.73M | 0.61%-423.33M | 11.64%-189.93M | 22.67%-425.94M |
Depreciation and amortization | -38.79%-118.97M | -21.92%-202.11M | -4.75%-85.72M | -3.78%-165.77M | -5.00%-81.84M | -8.99%-159.73M | -10.66%-77.94M | -7.20%-146.55M | -4.25%-70.43M | -27.98%-136.71M |
Special items of operating profit | -18.43%-5.31B | 1.70%-9.05B | -8.78%-4.48B | -38.77%-9.21B | -49.31%-4.12B | -70.70%-6.63B | -70.50%-2.76B | -30.34%-3.89B | -24.07%-1.62B | -19.58%-2.98B |
Operating profit | -19.59%193.65M | -15.03%569.72M | -12.43%240.84M | 91.52%670.46M | 187.78%275.03M | 396.97%350.08M | 379.38%95.57M | 139.28%70.44M | -2.93%19.94M | 12.53%29.44M |
Financing cost | 45.39%-8.54M | -104.03%-25.22M | -2,262.24%-15.64M | -1,250.93%-12.36M | -54.31%-662K | -58.30%-915K | -126.98%-429K | -7.43%-578K | 36.58%-189K | ---538K |
Share of profits of associates | ---- | -880.48%-4.47M | ---4.47M | 6.94%-456K | ---- | 73.51%-490K | 71.13%-278K | -235.14%-1.85M | -483.64%-963K | 8.91%-552K |
Earning before tax | -16.14%185.11M | -17.88%540.03M | -19.55%220.73M | 88.61%657.65M | 189.23%274.37M | 412.65%348.68M | 405.01%94.86M | 139.91%68.02M | -6.43%18.78M | 10.93%28.35M |
Tax | 47.92%-9.73M | 39.89%-58.95M | 53.88%-18.69M | -151.74%-98.08M | -588.93%-40.52M | -3,517.46%-38.96M | -877.08%-5.88M | 67.66%-1.08M | 78.68%-602K | 60.47%-3.33M |
After-tax profit from continuing operations | -13.20%175.38M | -14.03%481.08M | -13.60%202.04M | 80.67%559.57M | 162.80%233.84M | 362.70%309.72M | 389.39%88.98M | 167.54%66.94M | 5.40%18.18M | 46.03%25.02M |
Earning after tax | -13.20%175.38M | -14.03%481.08M | -13.60%202.04M | 80.67%559.57M | 162.80%233.84M | 362.70%309.72M | 389.39%88.98M | 167.54%66.94M | 5.40%18.18M | 46.03%25.02M |
Minority profit | 798.72%3.28M | 125.44%5.82M | 97.25%-469K | -26.56%-22.88M | -178.09%-17.03M | -962.85%-18.08M | ---6.13M | ---1.7M | ---- | ---- |
Profit attributable to shareholders | -15.02%172.1M | -18.40%475.26M | -19.28%202.51M | 77.69%582.45M | 163.79%250.88M | 377.57%327.8M | 423.07%95.11M | 174.34%68.64M | 5.40%18.18M | 46.03%25.02M |
Dividend | ---- | -17.39%150.4M | ---- | 64.84%182.06M | ---- | 200.37%110.45M | ---- | -80.76%36.77M | ---- | 2,499.92%191.15M |
Basic earnings per share | -15.12%0.219 | -22.96%0.604 | -25.22%0.258 | 73.84%0.784 | 167.44%0.345 | 384.95%0.451 | 416.00%0.129 | 173.53%0.093 | 4.17%0.025 | 47.83%0.034 |
Diluted earnings per share | -15.18%0.218 | -22.62%0.602 | -24.85%0.257 | 73.66%0.778 | 165.12%0.342 | 381.72%0.448 | 416.00%0.129 | 173.53%0.093 | 4.17%0.025 | 47.83%0.034 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.